Hyloris Pharmaceuticals SA HYL-BE:Euronext Brussels

*Data is delayed | EUR
Last | 5:29 PM CET
11.74quote price arrow down-0.06 (-0.51%)
Volume
7,069
52 week range
8.80 - 13.80

...

Loading . . .

KEY STATS

  • Open11.70
  • Day High11.74
  • Day Low11.50
  • Prev Close11.80
  • 52 Week High13.80
  • 52 Week High Date01/08/21
  • 52 Week Low8.80
  • 52 Week Low Date08/27/20
  • Market Cap366.05M
  • Shares Out25.59M
  • 10 Day Average Volume9,514
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-1.23
  • P/E (TTM)-9.57
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Hyloris Pharmaceuticals SA News

There is no recent news for this security.

Latest HYL-BE News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Hyloris Pharmaceuticals is a Belgium-based specialty pharmaceutical company. Its focus is on re-engineering cardiovascular products. Additionally, it also further develops and improves already-approved pharmaceuticals and established products, creating new and different solutions. The Company’s diverse product-development portfolio spans a wide range of therapeutic indications and dosage forms.
Address
Boulevard Gustave Kleyer 17
Liege
4000
Belgium